gastroesophageal cancer
Gastric Cancer Cases Frequently Harbor Genetic Risk Variants, Suggesting Germline Testing
Using panel sequence data for more than 500 esophagogastric cancer cases, researchers found pathogenic or likely pathogenic variants in almost 20 percent of those with gastric cancers.
Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors
Palmetto has expanded the local coverage determination for the Guardant360 liquid biopsy assay to be used with the majority of advanced solid tumors.
Broad Institute Launches Patient-Partnered Cancer Research Non-Profit Organization
Count Me In is aiming to sign up more than 100,000 patients across all major cancer types, as well as rare cancers, over the next several years.
Roche, Five Prime Therapeutics to Develop CDx Assays for Immuno-Oncology Drug Trials
Five Prime will use an IHC CDx to analyze the use of investigational drug candidates in patients with advanced gastric or gastroesophageal junction cancer.